Securities code: Xiamen Amoytop Biotech Co.Ltd(688278) securities abbreviation: Xiamen Amoytop Biotech Co.Ltd(688278) Announcement No.: 2022011 Xiamen Amoytop Biotech Co.Ltd(688278)
Announcement of resolutions of the third meeting of the eighth board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of supervisors
Xiamen Amoytop Biotech Co.Ltd(688278) (hereinafter referred to as “the company”) the third meeting of the eighth board of supervisors was held on March 30, 2022 by means of on-site voting combined with communication. The meeting has been notified to all supervisors by email on March 18, 2022. The meeting was presided over by Mr. Liu Jun, chairman of the board of supervisors. There were 3 supervisors and 3 supervisors. The meeting was held in accordance with the company law, the articles of association and other relevant provisions, and the resolutions of the meeting were legal and effective.
2、 Deliberation at the meeting of the board of supervisors
(I) deliberated and passed the proposal on the work report of the board of supervisors in 2021
The board of supervisors believes that in 2021, all members of the board of supervisors of the company faithfully, diligently and effectively performed their supervisory duties in strict accordance with relevant laws and regulations, normative documents, the articles of association and the rules of procedure of the board of supervisors, and actively safeguarded the legitimate rights and interests of the company and shareholders.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(II) deliberated and passed the proposal on the company’s 2021 annual financial statement report
The board of supervisors believes that the company’s 2021 financial report has been audited by Rongcheng Certified Public Accountants (special general partnership) and issued a standard unqualified audit report. The company has completed the annual financial settlement according to the actual operation in 2021, and the financial settlement report truly reflects the company’s financial situation and operating results.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(III) deliberated and passed the proposal on the company’s 2021 annual report and its summary
After comprehensively reviewing the company’s 2021 annual report and its summary, the board of supervisors issued the following opinions:
1. The contents of the company’s 2021 annual report and its summary objectively and truly reflect the financial situation and operating results in 2021.
2. The preparation of the company’s annual confidential report in 2021 did not comply with the provisions of laws and regulations and its internal control procedures.
3. All supervisors of the company guarantee that the information disclosed in the 2021 annual report and its summary is true, accurate and complete, and there are no false records, misleading statements or major omissions, and bear individual and joint liabilities for the authenticity, accuracy and integrity of its contents.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(IV) deliberated and passed the proposal on the company’s profit distribution plan in 2021
The board of supervisors believes that the company’s profit distribution plan for 2021 complies with the provisions of relevant laws and regulations and the articles of association. The plan fully considers the company’s current operating conditions and future development capital needs, and is in line with the interests of the company and all shareholders. Agree to this profit distribution plan and submit it to the general meeting of shareholders for deliberation. Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(V) deliberated and passed the proposal on continuing the appointment of accounting firms
The board of supervisors held that Rongcheng Certified Public Accountants (special general partnership) was able to strictly follow the independent, objective and fair practice standards during its tenure as the company’s audit institution in 2021, and the audit opinions issued objectively and truly reflected the company’s financial situation and operating results, and earnestly fulfilled the responsibilities of the audit institution. Agree to continue to appoint Rongcheng Certified Public Accountants (special general partnership) as the company’s audit institution in 2022 for one year, and agree to submit the proposal to the general meeting of shareholders for deliberation.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(VI) deliberated and passed the proposal on the company’s internal control evaluation report in 2021
The board of supervisors believes that the company has continuously improved the internal control management system in 2021, and the implementation effect of the internal control system has been continuously enhanced. The 2021 internal control evaluation report prepared by the company objectively reflects the operation of the internal control system.
Voting results: 3 in favor, 0 against and 0 abstention.
(VII) deliberated and passed the proposal on the special report on the deposit and actual use of the company’s raised funds in 2021
The board of supervisors believes that: the company has made special account storage and special use of the raised funds, there is no case of changing the purpose of the raised funds in a disguised manner and damaging the interests of shareholders, there is no case of illegal use of the raised funds, and the use of the raised funds complies with the provisions of relevant laws, regulations and normative documents.
Voting results: 3 in favor, 0 against and 0 abstention.
(VIII) deliberated and passed the proposal on using some idle self owned funds for cash management
The board of supervisors believes that through appropriate cash management of idle self owned funds, we can obtain certain investment income and better investment return for the company and shareholders. Combined with the actual use of the company’s own funds, it is agreed that the company will use the total amount of no more than 300 million yuan (including this amount) to temporarily idle its own funds for cash management for a period of 12 months. Within the above-mentioned period and amount, the funds can be used on a rolling basis.
Voting results: 3 in favor, 0 against and 0 abstention.
It is hereby announced.
Xiamen Amoytop Biotech Co.Ltd(688278) board of supervisors
March 31, 2022
